The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Increased Melatonin Signaling Is a Risk Factor for Type 2 Diabetes
Open accessAbstract
Type 2 diabetes (T2D) is a global pandemic. Genome-wide association studies (GWASs) have identified >100 genetic variants associated with the disease, including a common variant in the melatonin receptor 1 b gene (MTNR1B). Here, we demonstrate increased MTNR1B expression in human islets from risk G-allele carriers, which likely leads to a reduction in insulin release, increasing T2D risk. Accordingly, in insulin-secreting cells, melatonin reduced cAMP levels, and MTNR1B overexpression exaggerated the inhibition of insulin release exerted by melatonin. Conversely, mice with a disruption of the receptor secreted more insulin. Melatonin treatment in a human recall-by-genotype study reduced insulin secretion and raised glucose levels more extensively in risk G-allele carriers. Thus, our data support a model where enhanced melatonin signaling in islets reduces insulin secretion, leading to hyperglycemia and greater future risk of T2D. The findings also imply that melatonin physiologically serves to inhibit nocturnal insulin release.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The MTNR1B risk variant rs10830963 has a strong association with fasting glucose and confers increased expression of the melatonin receptor in human pancreatic islets (11).”
From Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial (2022) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“This melatonin receptor is a G-protein-coupled receptor that mainly acts via interfering with the formation of cAMP through inhibitory G proteins, inhibiting adenylate cyclase and subsequently inhibiting insulin release (11).”
From Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial (2022) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“The MTNR1B risk variant rs10830963 has a strong association with fasting glucose and confers increased expression of the melatonin receptor in human pancreatic islets (11).”
From Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial (2022) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“This difference might be partly due to the 3.5-fold higher melatonin concentrations, as supported by our earlier trial in which acute melatonin administration impaired glucose tolerance and in vitro b-cell experiments showing decreased insulin secretion due to melatonin (10,11,18,28).”
From Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial (2022) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“results shown in insulin-secreting cells (11) that demonstrated that MTNR1B overexpression augmented the inhibition of insulin release exerted by melatonin.”
From Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial (2022) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“Thus, our study supports the hypothesis that melatonin contributes to impaired glucose homeostasis by inhibiting insulin secretion”
From Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial (2022) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, while previous studies have shown that the association with fasting glucose during the day (typically morning) is robust and reproducible (11)”
From Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial (2022) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Visscher, P. M., Brown, M. A., McCarthy, M. I., & Yang, J. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.029 · Cited by 2,425
Adverse metabolic and cardiovascular consequences of circadian misalignment
Scheer, F. A. J. L., Hilton, M. F., Mantzoros, C. S., & Shea, S. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808180106 · Cited by 2,351
Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes
Marcheva, B., Ramsey, K. M., Buhr, E. D., Kobayashi, Y., Su, H., Ko, C. H., Ivanova, G., Omura, C., Mo, S., Vitaterna, M. H., et al. (2010) · Nature · doi:10.1038/nature09253 · Cited by 1,525
Clinical risk factors, DNA variants, and the development of type 2 diabetes
Lyssenko, V., Jonsson, A., Almgren, P., Pulizzi, N., Isomaa, B., Tuomi, T., Berglund, G., Altshuler, D., Nilsson, P., & Groop, L. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801869 · Cited by 938
Self-citationHohmeier, H. E., Mulder, H., Chen, G., Henkel-Rieger, R., Prentki, M., & Newgard, C. B. (2000) · Diabetes · doi:10.2337/diabetes.49.3.424 · Cited by 922
Variants in MTNR1B influence fasting glucose levels
Prokopenko, I., Langenberg, C., Florez, J. C., Saxena, R., Soranzo, N., Þorleifsson, G., Loos, R. J. F., Manning, A. K., Jackson, A., Aulchenko, Y. S., et al. (2008) · Nature Genetics · doi:10.1038/ng.290 · Cited by 743
Lyssenko, V., Nagorny, C. L. F., Erdos, M. R., Wierup, N., Jonsson, A., Spégel, P., Bugliani, M., Saxena, R., Fex, M., Pulizzi, N., et al. (2009) · Nature Genetics · doi:10.1038/ng.288 · Cited by 742
Prevention of fat-induced insulin resistance by salicylate
Kim, J. K., Kim, Y.-J., Fillmore, J. J., Chen, Y., Moore, I., Lee, J., Yuan, M., Li, Z. W., Karin, M., Perret, P., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11559 · Cited by 737
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–262 of 262
Odriozola, A., González, A., Álvarez‐Herms, J., & Corbi, F. (2024) · Advances in genetics · doi:10.1016/bs.adgen.2024.03.001 · Cited by 3
Genetic variants affect diurnal glucose levels throughout the day
Sinnott-Armstrong, N., Strausz, S. J., Urpa, L., Abner, E., Johnson, J. P., Valliere, J., Palumaa, T., FinnGen, Program, V. M. V., Palta, P., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-72432-6 · Cited by 3
Zhang, Y., Li, Q., Tan, H., & Nie, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21630-5.00015-0 · Cited by 2
Lima, A. C. D. S., Cruvinel, N. T., da Silva, N. R., Mendes, M. M., Duarte, A. C. S., Coelho, A. S. G., Vimaleswaran, K. S., & Horst, M. A. (2025) · Genes · doi:10.3390/genes16050497 · Cited by 2
“…variant is common and located within the single 11 kb intron of the MTNR1B gene, and the SNP has been associated with altered receptor expression or signaling efficiency, potentially leading to impaired β -cell function, reduced insulin secretion, and consequent insulin resistance [38–40].”
Clinical Implications of the Timed Autonomic Nervous System
Cardinali, D. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-57571-1_8 · Cited by 2
Asano, K., Tsukada, A., Yanagisawa, Y., Higuchi, M., Takagi, K., Ono, M., Tanaka, T., Tomita, K., & Yamada, K. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.13007 · Cited by 2
Magalhães, A., Barra, C., Borges, A., & Santos, L. C. (2022) · Diabetology · doi:10.3390/diabetology3040046 · Cited by 3
Chen, F., Fei, X., Li, M., Zhang, Z., Zhu, W., Zhang, M., Chen, X., Xu, J., Zhang, M., Shen, Y., et al. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01188-2 · Cited by 2
“The MTNR1B rs10830963 SNV is not only closely correlated with increased fasting plasma glucose (FPG) levels [42, 46, 47], but also with insulin resistance (HOMA-IR) [48], which disrupted the early-phase insulin response [49] in the development of GDM or T2DM.”
BackgroundOuyang, S., Su, Y., Ding, N., Su, Y., & He, L. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287090 · Cited by 2
“increasing blood sugar levels and increasing the risk of diabetes [25].”
BackgroundThe role of melatonin in type 2 diabetes and obesity
Przezak, A., Bielka, W., Arciszewski, M., & Banach, B. (2021) · Farmacja Polska · doi:10.32383/farmpol/133607 · Cited by 1
Role of Circadian Rhythm in Hormonal Cancers
Jyoti, D., Guleria, S., Ahsan, A. U., Chopra, M., & Sobti, R. C. (2024) · Springer eBooks · doi:10.1007/978-981-99-3746-2_25 · Cited by 1
Diabetes-associated Genetic Variation in MTNR1B and Its Effect on Islet Function
Vella, M., Mohan, S., Christie, H. E., Bailey, K. R., Cobelli, C., Man, C. D., Matveyenko, A. V., Egan, A. M., & Vella, A. V. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae130 · Cited by 1
“In contrast, others noted that genetic overexpression of the melatonin receptor in β -cells attenuates insulin secretion [40].”
BackgroundGoyal, V., & Tosini, G. (2024) · Journal of Pineal Research · doi:10.1111/jpi.70007 · Cited by 1
Association of MTNR1B Gene Polymorphisms with Body Mass Index in Hashimoto’s Thyroiditis
Škrlec, I., Biloglav, Z., Lešić, D., Talapko, J., Žabić, I., & Katalinić, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083667 · Cited by 1
Bolognesi, E., Carta, A., Guerini, F. R., Sotgiu, S., Agliardi, C., Dettori, C., Zanzottera, M., & Clerici, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115198 · Cited by 1
“Previous studies have shown increased MT2 receptor expression and altered melatonin secretion patterns in individuals carrying the G risk allele of rs10830963 [33,34].”
Li, J., Li, Y., Zhu, Y., Li, S., Lu, Y., & Tian, H. (2026) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514261432381 · Cited by 1
“15 In the regulation of bone metabolism, melatonin can act directly on osteoblasts and osteoclasts to promote bone formation and inhibit bone resorption through the regulation of classical signaling pathways, such as Wnt/ β -catenin and RANKL/OPG, thereby maintaining bone homeostasis.”
Tecucianu, R., Tunaru, S., & Petrescu, S. M. (2026) · Diabetology · doi:10.3390/diabetology7040068 · Cited by 1
Dias, G. Z. T., Tessarin, G. W. L., Ferreira, R. L., de Souza, K. B., Toro, L. F., Nobumoto, A. C. T. Y., & dos Santos, R. M. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113290 · Cited by 2
Ying, H., Wang, Q., He, Q., Cao, Y., Wei, G., Xiao, Z., & Luo, X. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1834999 · Cited by 1
“Current explanations for nocturnal glycemic dysregulation primarily focus on increased endogenous glucose production (EGP) during the night (Tuomi et al., 2016).”
Melatonin signalling implicated in the risk of T2DM
Greenhill, C. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.85 · Cited by 1
Fluorescent Translocation Reporters for Sub–plasma Membrane cAMP Imaging
Dyachok, O., Xu, Y., Idevall‐Hagren, O., & Tengholm, A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2245-2_20 · Cited by 1
Zheng, T., Liu, J.-H., Huang, W.-T., Hong, B., Wang, D., Liu, C.-Y., Zhang, J., Li, S., Wu, S., Wang, Q., et al. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i5.103602 · Cited by 1
Impact of Melatonin on Brain Metabolism in Diabetes: A Narrative Review
Nwaji, A. R., Bisong, S. A., Antai, A. B., Okakpu, C. M., Okechukwu, M. P., Igwe, E. O., Okafor, C., Odoh, P. C., Chukwu, M. C., Esinulo, J. I., et al. (2025) · Natural Product Communications · doi:10.1177/1934578x251340772 · Cited by 2
“77,93 This approach fi rst appears straightforward and consistent with the phenotype of risk allele bearers, which includes elevated FPG levels and T2DM risk.”
Karpovich, А. A., Snezhitskiy, V. А., & Shyshko, V. I. (2020) · Journal of the Grodno State Medical University · doi:10.25298/2221-8785-2020-18-3-243-247 · Cited by 1
Major clinical outcomes of melatonin regulation in obesity: a systematic review
Ribeiro, D. D. S. (2023) · MedNEXT Journal of Medical and Health Sciences · doi:10.54448/mdnt23101 · Cited by 1
“Thus, the time domain is a critical factor to be considered in chronic MEL treatments [39], as the molecule has the unique characteristic of being a hormone that regulates the body's physiology and behavior [40].”
Al-Fartosi, K. G., Jabbar, E. A. K., & Jabbar, A. A. (2019) · University of Thi-Qar Journal of Science · doi:10.32792/utq/utjsci/v7i1.240 · Cited by 1
Singh, T., Kalamajski, S., Cunha, J. G. D., Hladkou, S., Roberts, F. L., Gheibi, S., Soltanian, A. R., Farahmand, K. Y., Ekström, O., Mamidi, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.19.603674 · Cited by 1
“There is strong evidence that the common MNTR1B variant (rs10830963) is associated with increased T2D risk [2, 16, 44-49], and perturbed -cell function.”
BackgroundLacouchie, J. (2024) · medRxiv · doi:10.1101/2024.10.02.24314765 · Cited by 1
PARMAR, N. R., Patel, R., RATHWA, N. N., Dwivedi, M., Begum, R., & Ramachandran, A. V. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.17.639558 · Cited by 1
“The findings of melatonin regulating glucose metabolism via increased PI3K-Akt activity [35,43] support our findings.”
Sleep, dietary patterns and metabolic health in UK adults
Potter, G. D. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
O papel da melatonina na regulação do tecido adiposo marrom
Halpern, B. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-31102018-131724
van Faassen, M. H. J. R. (2020) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.134196271
Cytoprotection by Melatonin: The Metabolic Syndrome as an Example
Cardinali, D. P., & Vigo, D. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-61721-9_22
Targeting Islet GPCRs to Improve Insulin Secretion
Atanes, P., Ruz‐Maldonado, I., & Persaud, S. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00050-5 · Cited by 1
Molekulargenetische Diagnostik des Diabetes mellitus
Grallert, H., & Warncke, K. (2022) · Die Diabetologie · doi:10.1007/s11428-022-00876-7
Hardeland, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.62140-2
Faculty Opinions recommendation of Transcriptional architecture of the mammalian circadian clock.
Ueda, H. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727120964.793558641
Tosini, G., Tchio, C. I. M., Musani, S. K., & Quarshie, A. (2020) · doi:10.21203/rs.3.rs-88596/v1
Islet Inflammation and Metabolic Homeostasis
Collier, J. J., & Burke, S. J. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-0927-3
A 24-hour perspective on insulin resistance
Harmsen, J. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231213jh
Circadian Clock Signals in Endocrine Glands
Tominaga, K., & Okamura, H. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781839167553-00246
The Beat Goes On: The Impact of Circadian Rhythms on insulin resistance
Xia, J. (2024) · Science and Technology of Engineering Chemistry and Environmental Protection · doi:10.61173/5wh6re37
Guo, H., Peng, H., Wang, S., Hou, T., Li, Y., Zhang, H., Wang, M., Wu, Y., Qin, X., Tang, X., et al. (2024) · PubMed Central · doi:10.19723/j.issn.1671-167x.2024.03.001
سیستمهای سیرکادیان انسانی و تأثیر اختلالات آن بالای فعالیت انسولین
عظیمی, ض. (2025) · Journal of Natural Sciences – Kabul University · doi:10.62810/jns.v4i2.214
Sørensen, K. V., Justesen, J. M., Ängquist, L. H., Bork‐Jensen, J., Hartmann, B., Jørgensen, N. R., Rungby, J., Sørensen, H. T., Vaag, A. A., Nielsen, J. S., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06381-y
“…impaired-function variants molecularly impair MT2 signalling [14]; hence, both impaired MT2 signalling and enhanced MTNR1B expression (potentially enhancing signalling), as observed for the rs10830963 variant [4, 39], may increase glucose levels, potentially through a diminished insulin response.”
Руслановна, В. Э., & Kuznetsova, I. V. (2025) · Medical alphabet · doi:10.33667/2078-5631-2025-7-28-35
Broussard, J. L., Hanlon, E. C., & Tasali, E. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197756782.003.0015
Social jetlag, circadian disruption, and cardiometabolic disease risk
Malone, S. K., Mendoza, M. A., & Patterson, F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13954-3.00040-1
Wen, Y.-L., Huang, Y.-C., Liao, C.-C., Kao, S., Pan, K., Yang, H.-W., To, S.-Y., Yeh, C. B., & Kao, L. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02130-2
“Some genetic studies have suggested that melatonin might inhibit insulin secretion, particularly in individuals with MTNR1B risk alleles [28, 29].”
Timing of coffee consumption and insulin resistance: evidence from human and animal studies
Liu, P., Yao, G., Wu, Y., & Zhou, Q. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1775412
“The hypothalamic suprachiasmatic nucleus (SCN), serving as a central brain clock of the circadian system, misregulates the function of peripheral metabolic organs through dysregulated autonomic nervous system signaling and hormonal pathways (particularly cortisol and melatonin rhythms) (26 – 29).”
Melatonin improves postprandial hypoglycemia: an unusual presentation of insulinoma
Nguyen, T., Matveyenko, A. V., & Smushkin, G. (2026) · JCEM Case Reports · doi:10.1210/jcemcr/luag067
“Importantly, the activation of melatonin receptors in pancreatic β -cells in vitro leads to a robust reduction in insulin secretion, and the attenuation of β -cell stress [6-8].”
Zolubaite, M., Mekouar, Z. M., & Barrow, M. (2026) · Physiology & Behavior · doi:10.1016/j.physbeh.2026.115484
Gheorghiu, M., & Trandafir, M.-F. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48090884
“In contrast, there is no difference in the number of MT2Rs between the two cell types [20].”
Genome-wide association and polygenic risk score analysis of prediabetes in South Indian womenPreprint
S., G. K., Tarun Sanjai, G., Mathews, E., & Manickavelu, A. (2026) · Research Square · doi:10.21203/rs.3.rs-10628165/v1
Goyal, V., & Tosini, G. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1884802
“However, except for one study (10), all other studies have been performed in male mice and little attention has been placed on the possible role that melatonin signaling may play in female mice.”
Waseem, S., Zhan, J., Yu, L., & Xiao, X. (2026) · Reproductive Sciences · doi:10.1007/s43032-026-02196-3
“M T N R 1 B s i gn a li ng li nk e d t o i n s u li n s ec r e ti on & s e n s iti v it y ; c i r ca d i a n e n t r a i n - m e n t o f g l u c o s e m e t a b o li s m [ 99– 102 ] .”
Haskologlu, I. C., & Özünal, Z. G. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198473
“Mechanistically, MTNR1B risk variants may increase melatonin receptor signaling in pancreatic β -cells, thereby enhancing the inhibitory effect of melatonin on insulin secretion [122].”
(2019) · University of Thi-Qar Journal of Science · doi:10.32792/utq/utjsci/vol7/1/1
“The association between type 2 diabetes and some genetc variants within the MTNR1B gene was reported in several portions around the world (Valeriya et al., 2009: Tuomi et al., 2016).”
BackgroundWang, X., Cao, Y., Sun, Z., Liang, S., Sun, C., Gao, J., Zhang, Z., & Yang, W. (2026) · Sleep Health · doi:10.1016/j.sleh.2026.09.008
Mui, W.-C., Hou¹, Y.-C., Liao, Y., & Lu, K. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1960152
BindingDB Entry 50014387: Discovery of
BindingDB (2022) · UC San Diego · doi:10.7270/q2z03czj
Metadata
- Authors
- Tuomi, T., Nagorny, C. L. F., Singh, P., Bennet, H., Yu, Q., Alenkvist, I., Isomaa, B., Östman, B., Söderström, J., Pesonen, A.-K., Martikainen, S., Räikkönen, K., Forsén, T., Hakaste, L., Almgren, P., Storm, P., Asplund, O., Shcherbina, L., Fex, M., Fadista, J., Tengholm, A., Wierup, N., Groop, L., & Mulder, H.
- Affiliations
- Lund University (SE)
- Uppsala University (SE)
- University of Helsinki (FI)
- Folkhälsans Forskningscentrum (FI)
- Corresponding author
- Mulder, Hindrik
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 23
- Issue
- 6
- Pages
- 1067-1077
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2367683267
- Cited by
- 262
- References
- 44
- Citations by year
- 2026: 17 · 2025: 27 · 2024: 20 · 2023: 17 · 2022: 17 · 2021: 28 · 2020: 29 · 2019: 27 · 2018: 36 · 2017: 30 · 2016: 13
- FWCI
- 39.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- Funders
- Helsingin ja Uudenmaan Sairaanhoitopiiri
- Finska Läkaresällskapet
- Folkhälsanin Tutkimussäätiö
- European Foundation for the Study of Diabetes
- Lunds Universitet (2009-1039)
- Novo Nordisk
- Signe ja Ane Gyllenbergin Säätiö
- Vetenskapsrådet (349-2006-237, 325‐2012‐6778, 2010-03490, 521-2012-2119, 2006–237, 2009-1039, 521-2010-3490)
- Samfundet Folkhälsan
- Sigrid Juséliuksen Säätiö
- Svenska Kulturfonden
- Paavo Nurmen Säätiö
- Novo Nordisk Fonden (NNF14OC0010995, NNF14OC0010363)
- Diabetestutkimussäätiö
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 2 diabetes, melatonin signaling, MTNR1B, insulin secretion, pancreatic islets, cyclic AMP, genetic risk variants, hyperglycemia, melatonin treatment
- MeSH terms
- Insulin Secretion, Cyclic AMP, Animals, Diabetes Mellitus, Type 2, Glucose, Heterozygote, Humans, Insulin, Melatonin, Risk Factors, Signal Transduction, Mice, Knockout, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Quantitative Trait Loci, Receptors, Melatonin, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
